C, S., Y, G., A, S., Q, S., CJ, P., T, L., . . . JS, M. (2018). Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors. Cardiovascular toxicology, 18(2), 184. https://doi.org/10.1007/s12012-017-9429-8
Chicago Style (17th ed.) CitationC, Shah, Gong Y, Szady A, Sun Q, Pepine CJ, Langaee T, Lucas AR, and Moreb JS. "Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors." Cardiovascular Toxicology 18, no. 2 (2018): 184. https://doi.org/10.1007/s12012-017-9429-8.
MLA (9th ed.) CitationC, Shah, et al. "Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors." Cardiovascular Toxicology, vol. 18, no. 2, 2018, p. 184, https://doi.org/10.1007/s12012-017-9429-8.